Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001557150 | SCV001778861 | pathogenic | not provided | 2021-11-23 | criteria provided, single submitter | clinical testing | Canonical splice site variant expected to result in aberrant splicing, although in the absence of functional evidence the actual effect of this sequence change is unknown.; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 29861108) |
3billion, |
RCV001775176 | SCV002012167 | likely pathogenic | Intellectual disability, autosomal dominant 57 | 2021-10-02 | criteria provided, single submitter | clinical testing | Canonical splice site: predicted to alter splicing and result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is not observed in the gnomAD v2.1.1 dataset (PM2). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. |
Revvity Omics, |
RCV001775176 | SCV002018976 | pathogenic | Intellectual disability, autosomal dominant 57 | 2021-03-11 | criteria provided, single submitter | clinical testing | |
Centre de Biologie Pathologie Génétique, |
RCV001775176 | SCV002559212 | pathogenic | Intellectual disability, autosomal dominant 57 | criteria provided, single submitter | clinical testing |